Literature DB >> 1479448

Excitotoxic acid lesions of the primate subthalamic nucleus result in transient dyskinesias of the contralateral limbs.

I Hamada1, M R DeLong.   

Abstract

1. To examine the role of the subthalamic nucleus (STN) in the pathogenesis of dyskinesias, the STN was experimentally lesioned with fiber-sparing excitotoxins in two awake monkeys. 2. A combined recording-injection device was used to locate and lesion the STN accurately under physiological guidance. A small amount (1 microliters) of ibotenic acid (10 micrograms/microliters) or kainic acid (1 micrograms/microliters) was injected into each of four to seven target sites in the STN. Postmortem histology confirmed that lesions were confined to the STN, and the volume of each lesion at each site was 4-11% of the total volume of the nucleus. 3. Approximately 20 min after the end of each injection, the frequency of movements increased in the distal portions of the upper and lower limbs contralateral to the injection site. Severe dyskinesias, involving the proximal joints to a greater degree than the distal, developed in the contralateral limbs after 60-80 min and lasted < or = 4 h. The pattern of involvement and time course were similar after each lesion. In the days after the lesioning, only rare dyskinesias were observed in the contralateral hands and feet, typically occurring when the animals were stimulated. 4. Despite the severe dyskinesias, there was no obvious effect on voluntary movements such as grooming or reaching. 5. These results suggest that reduction of STN activity plays a role in the production of dyskinesias.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1479448     DOI: 10.1152/jn.1992.68.5.1850

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  33 in total

1.  Postural and anticonvulsant effects of inhibition of the rat subthalamic nucleus.

Authors:  D Dybdal; K Gale
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

2.  Activity of neurons of the subthalamic nucleus in relation to motor performance in the cat.

Authors:  F Cheruel; J F Dormont; D Farin
Journal:  Exp Brain Res       Date:  1996-03       Impact factor: 1.972

3.  Subthalamic nucleus neurons switch from single-spike activity to burst-firing mode.

Authors:  C Beurrier; P Congar; B Bioulac; C Hammond
Journal:  J Neurosci       Date:  1999-01-15       Impact factor: 6.167

Review 4.  Milestones in research on the pathophysiology of Parkinson's disease.

Authors:  Thomas Wichmann; Mahlon R DeLong; Jorge Guridi; Jose A Obeso
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

5.  Movement-related discharge in the macaque globus pallidus during high-frequency stimulation of the subthalamic nucleus.

Authors:  Andrew J Zimnik; Gerald J Nora; Michel Desmurget; Robert S Turner
Journal:  J Neurosci       Date:  2015-03-04       Impact factor: 6.167

Review 6.  On the Globality of Motor Suppression: Unexpected Events and Their Influence on Behavior and Cognition.

Authors:  Jan R Wessel; Adam R Aron
Journal:  Neuron       Date:  2017-01-18       Impact factor: 17.173

Review 7.  Pathological basal ganglia activity in movement disorders.

Authors:  T Wichmann; J O Dostrovsky
Journal:  Neuroscience       Date:  2011-06-22       Impact factor: 3.590

8.  HCN channels modulate the activity of the subthalamic nucleus in vivo.

Authors:  Wen-Shuai Deng; Yun-Xia Jiang; Xiao-Hua Han; Yan Xue; Hua Wang; Peng Sun; Lei Chen
Journal:  J Mol Neurosci       Date:  2014-05-21       Impact factor: 3.444

9.  Loss of Hyperdirect Pathway Cortico-Subthalamic Inputs Following Degeneration of Midbrain Dopamine Neurons.

Authors:  Hong-Yuan Chu; Eileen L McIver; Ryan F Kovaleski; Jeremy F Atherton; Mark D Bevan
Journal:  Neuron       Date:  2017-09-13       Impact factor: 17.173

10.  Cortical Control of Subthalamic Neuronal Activity through the Hyperdirect and Indirect Pathways in Monkeys.

Authors:  Zlata Polyakova; Satomi Chiken; Nobuhiko Hatanaka; Atsushi Nambu
Journal:  J Neurosci       Date:  2020-08-26       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.